NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
25 April 2025
| Name: | LIVING CELL TECHNOLOGIES LIMITED (LCT) (This company subsequently changed its name to ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Status.) | ||||||
| ISIN: | AU000000LCT6 | ||||||
| Date of Listing: | 01 September 2004 | ||||||
| Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 104 028 042ABN: 14 104 028 042
Registration Date: 17 March 2003
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now ALGORAE PHARMACEUTICALS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| ALGORAE PHARMACEUTICALS LIMITED | 11/09/2023 | |
| LIVING CELL TECHNOLOGIES LIMITED | 11/09/2023 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Algorae Pharmaceuticals Limited | 11/09/2023 |
The suspension of trading in the securities of Living Cell Technologies Limited will be lifted immediately, following release of an announcement regarding a capital raising. | 30/11/2016 |
Living Cell Technologies Limited has completed the placement of 74,117,647 shares at $0.085 to institutional and professional investors, raising $6.3m. The funds will be used for working capital to continue research and development, including completing the Phase IIb clinical trial of NTCELL for Parkinson's disease and treating the placebo patients at the most effective dose. | 30/11/2016 |
The securities of Living Cell Technologies Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 28/11/2016 |
shares reinstated to quotation | 30/07/2009 |
shares suspended from quotation pending an announcement | 29/07/2009 |
shares reinstated to quotation | 30/10/2007 |
shares suspended from quotation pending an announcement | 29/10/2007 |
delisted from the Newcastle Stock Exchange today as the company had successfully applied to list its securities on ASX | 01/09/2004 |
name changed to Algorae Pharmaceuticals Limited | 11/09/2023 |
The suspension of trading in the securities of Living Cell Technologies Limited will be lifted immediately, following release of an announcement regarding a capital raising. | 30/11/2016 |
Living Cell Technologies Limited has completed the placement of 74,117,647 shares at $0.085 to institutional and professional investors, raising $6.3m. The funds will be used for working capital to continue research and development, including completing the Phase IIb clinical trial of NTCELL for Parkinson's disease and treating the placebo patients at the most effective dose. | 30/11/2016 |
The securities of Living Cell Technologies Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. | 28/11/2016 |
shares reinstated to quotation | 30/07/2009 |
shares suspended from quotation pending an announcement | 29/07/2009 |
shares reinstated to quotation | 30/10/2007 |
shares suspended from quotation pending an announcement | 29/10/2007 |
delisted from the Newcastle Stock Exchange today as the company had successfully applied to list its securities on ASX | 01/09/2004 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 08/09/2022 | Robert Willcocks | 500,000 | $0.013 | $6,500 |
| 06/06/2022 | Carolyn Sue | 1,000,000 | $0.007 | $7,000 |
| 03/06/2022 | Robert Willcocks | 1,000,000 | $0.007 | $7,000 |
| 06/11/2018 | Robert Elliott | 210,000 | $0.046 | $9,660 |
| 04/09/2018 | Robert Elliott | 123,000 | $0.029 | $3,567 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Belinda Di Bartolo | COO | 13/12/2021 |
| John Cowan | CFO | 20/10/2008 |
| Laurie Hunter | Independent Director | 25/08/2006 |
| Bradley Latham | Non Exec Director | 03/07/2023 |
| Bradley Dilkes | Director | 31/10/2022 |
| David Hainsworth | Director | 31/10/2022 |
| Madhukar Bhalla | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Carolyn Sue | Non Exec Director | 16/05/2019 | 01/07/2023 |
| Bernard Tuch | Interim CEO | 20/07/2011 | 28/12/2022 |
| Robert Willcocks | Independent Director | 29/03/2011 | 31/10/2022 |
| Andrew Kelly | Non Exec Director | 08/11/2019 | 31/10/2022 |
| Janice Lam | COO | 11/04/2018 | 27/08/2021 |
| Ken Taylor | Executive Director, CEO | 01/04/2014 | 16/07/2021 |
| Robert Elliott | Executive Director | 15/01/2004 | 21/08/2020 |
| Roy Austin | Chairman, Independent Director | 25/02/2011 | 31/08/2018 |
| Andrea Grant | Managing Director, CEO | 16/01/2012 | 01/04/2014 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
